| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 85.56M | 176.30M | 169.52M | 199.10M | 217.12M |
| Gross Profit | 31.70M | 45.37M | 28.64M | 42.82M | 39.74M |
| EBITDA | -18.26M | -10.37M | -12.78M | 2.59M | 8.42M |
| Net Income | -26.75M | -21.97M | -19.57M | -1.94M | 4.75M |
Balance Sheet | |||||
| Total Assets | 360.88M | 415.19M | 427.50M | 380.67M | 391.73M |
| Cash, Cash Equivalents and Short-Term Investments | 9.63M | 26.73M | 38.73M | 28.81M | 25.02M |
| Total Debt | 133.61M | 159.50M | 140.55M | 85.61M | 88.62M |
| Total Liabilities | 143.48M | 172.82M | 164.17M | 99.87M | 110.58M |
| Stockholders Equity | 217.40M | 242.36M | 263.33M | 280.80M | 281.15M |
Cash Flow | |||||
| Free Cash Flow | 19.18M | -35.59M | -49.77M | -4.79M | -25.08M |
| Operating Cash Flow | 19.31M | -34.93M | -49.13M | -4.22M | -24.47M |
| Investing Cash Flow | -557.00K | 20.19M | -7.75M | 11.81M | 813.00K |
| Financing Cash Flow | -21.75M | 11.23M | 60.41M | -15.23M | 27.36M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$31.47M | 11.78 | 16.99% | 6.25% | 11.36% | 9.52% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | HK$605.00M | 3.36 | 3.54% | ― | 8.78% | 160.00% | |
47 Neutral | HK$81.20M | -17.33 | 5.29% | ― | 9.71% | ― | |
46 Neutral | HK$86.81M | -1.99 | -30.01% | ― | -58.81% | -10.51% | |
45 Neutral | HK$113.94M | -1.21 | -18.12% | ― | -7.93% | 45.04% | |
44 Neutral | HK$61.88M | -1.35 | -15.45% | ― | -43.22% | -34.69% |